You are here

Article Text

Article menu
Download PDFPDF
Editorial
The cost of cardiovascular disease: rising, declining or staying still?
  1. G Lyratzopoulos
  1. Correspondence to:
    Dr Georgios Lyratzopoulos
    Norfolk, Suffolk and Cambridgeshire, Strategic Health Authority, Victoria House, Capital Park, Fulbourn, Cambridge, CB1 5XB, UK; georgios.lyratzopoulos{at}nscsha.nhs.uk

Abstract

Epidemiological, demographic and health technology factors combined are likely to inflate future healthcare CVD costs, with an older and healthier population consuming higher levels of resources required for treatment

  • CVD, cardiovascular disease
  • CHD, coronary heart disease
  • MI, myocardial infarction
  • PCI, percutaneous coronary intervention
  • cost
  • cardiovascular
  • disease
  • health
  • economics

https://doi.org/10.1136/hrt.2005.085563

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Published Online First 18 April 2006

    • Competing interest statement: The author declares that he has no competing interest.